Too Many Older Men Are Still Screened for Prostate Cancer

Last summer, Joe Loree made an appointment to see his urologist. He’d occasionally noticed blood in his urine and wanted to have that checked out. His doctor ordered a prostate-specific…

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers — ScienceDaily

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a…

Prostate cancer: Most men can avoid or delay harsh treatments, long-term study confirms

CNN  —  Most men who are diagnosed with prostate cancer can delay or avoid harsh treatments without harming their chances of survival, according to new results from a long-running study…

Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer — ScienceDaily

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease — from its beginning to the point of androgen independence, where the tumour…

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk — ScienceDaily

Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive…

Prognosis of prostate cancer patients improved — ScienceDaily

Prostate cancer is the most common form of cancer in male in Sweden. Researchers at Umeå University in Sweden have now discovered a faster and easier way to determine who…

Common prostate cancer medications may be less safe than previously thought — ScienceDaily

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious…

Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases — ScienceDaily

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with…

Portable prostate cancer test may help reach underserved men — ScienceDaily

A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care,…